leisure time -WSS

leisure time

author：knowledge 2025-09-29 22:53:38 - browse：3

Multiple syringes in a vial -- Pharma coverage from STAT — Adobe

Roughly two million Americans are expected to receive a cancer diagnosis this year. Some members of this already vulnerable group will wind up facing what physician Andrew Schuman recently called “a tragedy happening in slow motion” — an ongoing, nationwide shortage of critical oncology drugs that routinely save or extend the lives of children and adults.

Speaking at a March 22 Senate hearing on drug shortages, Schuman, a head and neck surgeon at the U.S. Department of Veterans Affairs, described the agonizing decisions that doctors must make when critical medicines are in short supply. “Should our limited vials go to an older woman who was just diagnosed with lung cancer? To a young man who had already been successfully taking it for his testicular cancer? Or a baby with neuroblastoma?” he asked. “As a doctor who has devoted my life to fighting cancer, it is hard to express how horrible it is to face this kind of tragedy.”

The dilemmas caused by cancer drug shortages are unfortunately nothing new. In the past decade alone, eight of the 10 drugs most commonly used to treat acute lymphoblastic leukemia, the most common kind of childhood cancer type of leukemia, have been temporarily unavailable. The problem has been getting worse: Nationwide shortages of critical drugs increased nearly 30% in 2022, soaring to their highest level in nearly five years, according to a report released by the Senate Homeland Security and Governmental Affairs Committee for the hearing. Oncology drugs currently in short supply include methotrexate, which treats breast and soft tissue cancers; cisplatin, which treats testicular, ovarian, bladder, head and neck, lung, and cervical cancers; fluorouracil, which treats skin cancer; Pluvicto, for prostate cancer; and the injectable bacillus Calmette-Guérin, for bladder cancer.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Cancer drug shortages should be causing more outrage
Next article： Argenx readies a blockbuster opportunity with drug for autoimmune disease

focus

WSS

YouTube cracks down on misinformation on cancer treatment

Illinois Supreme Court finds assault weapons ban constitutional

Be careful with at

Biogen’s boardroom scandal saddles CEO with first crisis

BMS, looking to build heart drug business, turns to AI for diagnosis

Illumina slashes 2023 revenue projections yet again

Wikipedia

leisure time

Wikipedia

How one medical school became remarkably diverse

Argenx readies a blockbuster opportunity with drug for autoimmune disease

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Indictment alleges Trump's ex

Cancer drug shortages should be causing more outrage

Mark Cuban is blaming the wrong people for high drug costs

Bright Health sells Medicare Advantage business to Molina

Surge in Apellis stock fueled by confidence in safety of its eye drug

United colonoscopy coverage change 'may cost lives,' doctors say

Gene editing the human germline: What are the risks?

knowledge

Judge sides with young activists in first

Yogurt drink instead of a colonoscopy? CRISPR bacteria are tested

AstraZeneca to buy developer of next

Biogen’s boardroom scandal saddles CEO with first crisis

App could help diagnose ear infections more accurately — and at home

Biogen’s boardroom scandal saddles CEO with first crisis

hotspot

knowledge

focus

knowledge